Stock DNA
Pharmaceuticals & Biotechnology
CNY 3,753 Million (Mid Cap)
22.00
NA
1.48%
-0.18
9.49%
2.12
Revenue and Profits:
Net Sales:
367 Million
(Quarterly Results - Jun 2025)
Net Profit:
52 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.66%
0%
-5.66%
6 Months
23.58%
0%
23.58%
1 Year
43.02%
0%
43.02%
2 Years
16.48%
0%
16.48%
3 Years
22.71%
0%
22.71%
4 Years
21.18%
0%
21.18%
5 Years
22.74%
0%
22.74%
Hefei Lifeon Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-8.26%
EBIT Growth (5y)
-3.99%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
1.04
Tax Ratio
12.70%
Dividend Payout Ratio
59.64%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.15%
ROE (avg)
12.11%
Valuation key factors
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
2.12
EV to EBIT
25.55
EV to EBITDA
15.00
EV to Capital Employed
2.37
EV to Sales
2.35
PEG Ratio
NA
Dividend Yield
1.48%
ROCE (Latest)
9.27%
ROE (Latest)
9.49%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
367.00
428.80
-14.41%
Operating Profit (PBDIT) excl Other Income
54.00
71.50
-24.48%
Interest
1.10
0.60
83.33%
Exceptional Items
0.20
0.50
-60.00%
Consolidate Net Profit
52.30
48.50
7.84%
Operating Profit Margin (Excl OI)
83.60%
121.90%
-3.83%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is -14.41% vs -5.07% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 7.84% vs -25.38% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,496.10
1,882.50
-20.53%
Operating Profit (PBDIT) excl Other Income
237.70
254.30
-6.53%
Interest
2.00
1.40
42.86%
Exceptional Items
-4.10
0.50
-920.00%
Consolidate Net Profit
152.50
233.90
-34.80%
Operating Profit Margin (Excl OI)
101.10%
109.90%
-0.88%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -20.53% vs -26.56% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -34.80% vs 11.81% in Dec 2023
About Hefei Lifeon Pharmaceutical Co., Ltd. 
Hefei Lifeon Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






